SUMMARY Certain manifestations of alterations of membrane cytoskeleton, protein kinase C activity, and ion transport were revealed in erythrocytes of patients with essential hypertension: 1) the average volume of erythrocytes is reduced by 4%; 2) about 7% of the total number of erythrocytes is represented by cup-shaped forms compared with 1.5 to 3.0% in the control group; 3) basal phospborylation of Band 4.9 protein is increased 1.6-fold to 1.8-fold; 4) activity of protein kinase C is increased by 60 to 70%; 5) the rate of proton electrochemical gradient (A/i H +)-induced Na + -H + exchange is increased twofold. Treatment of erythrocytes of healthy donors with protein kinase C activator (12-O-tetradecanoylphorbol-13-acetate) leads to similar but more marked changes in cell shape (17% of cup-shaped forms), volume reduction (by 7%), an increase of Band 4.9 protein phosphorylation (threefold), and an increase in the rate of Na + -H + exchange (fourfold). Protein kinase activation does not modify Na + -Li + exchange and slightly increases (by 20-50%) Na + -K + pump activity, Na + -K + cotransport, and the rate of ^a influx. It may be assumed that the increase of protein kinase C activity is one of the most probable molecular mechanisms conditioning abnormalities of the membrane skeleton and Na + -H + exchange in primary hypertension. 
kinase. The existence of abnormalities in the erythrocyte membrane skeleton in primary hypertension is borne out by the decreased deformability of these cells in essential hypertension 4 and the reduction of erythrocyte volume described earlier in rats with spontaneous hypertension, the SHR 3 and Milan hypertensive 6 strains. Taking these data into account, we undertook the study of membrane skeleton protein phosphorylation, as well as cell shape and volume (as cytoskeletonKlependent parameters) in erythrocytes of patients with essential hypertension. We also attempted to characterize the state of the Na + -K + pump, the system of facilitated diffusion of univalent cations (Na + -K + cotransport, Na + -Li + and Na + -H + countertransport), and the ^Ca influx rate. All the data obtained were compared with similar data obtained under protein kinase C stimulation by 12-Otetradecanoylphorbol-13-acetate (TPA) in the erythrocytes of healthy subjects. We also performed a direct estimation of protein kinase C activities in VOL 12, No 3, SEPTEMBER 1988 membrane-free lysate of erythrocytes of hypertensive and normotensive subjects.
Subjects and Methods Donors
Blood samples were taken from the following groups 1) 49 patients with clinically established hypertension, World Health Organization Stages II and III (40 men and 9 women; mean age, 49.0 ± 2.4 years, blood pressure range, 170-215/105-115 mm Hg); 2) 18 patients with hypertension of renal origin (12 men and 6 women; mean age, 55.2 ± 4.7 years; blood pressure range, 190-220/100-125 mm Hg); and 3) 43 healthy normotensive subjects (36 men and 7 women; mean age, 47.2 ± 4.6 years; blood pressure range, 110-120/70-85 mm Hg), used as controls. In all patients in the second group, hypertension was caused by glomerulonephritis without renal insufficiency.
Blood samples were obtained (after subjects had fasted 10-12 hours) and stored with heparin (30-40 lU/ml) on ice no more than 3 hours before experiments were begun.
Ervthrocytes
After sedimentation of blood samples (2000 g for 10 minutes at 0-2 °C), plasma and white blood cells were removed and erythrocytes were washed twice with 5 ml of a medium containing 150 mM of NaCl and 5 mM of sodium phosphate buffer (pH 7.4). To determine the rate of Na + -Li + countertransport, erythrocytes were washed with a medium containing 75 mM MgCl 2 , 85 mM sucrose, 10 mM glucose, and 10 mM HEPES-Tris (pH 7.4).
Phosphorylation of Erythrocyte Membrane Proteins
The aliquots of erythrocytes washed with Medium A were preincubated for 1.5 hours at 38 °C in the same medium containing 0.7 to 0.9 mCi/ml of [ 32 P]orthophosphate (hematocrit, 30%). Medium A consisted of 130 mM NaCl, 0.01 mM CaCl 2 , 0.01 mM MgCl 2 , 20 mM glucose, and 35 mM Tris HC1 (pH 7.4). Protein kinase A and C were activated during a 10-minute incubation with 1 mM of dibutyryl-cyclicadenosine 3',5'-monophosphate (cAMP) and 1 fiM ^phorbol ester (TPA), respectively. After incubation, the samples were diluted with 40 volumes of 5 mM sodium phosphate buffer (pH 8.0, 2-4 °C) and centrifuged at 25,000 rpm for 25 minutes. Erythrocyte ghosts were washed under the same conditions, transferred in 2.5% sodium dodecyl sulfate containing 1% 2-mercaptoethanol, 20% glycerin, 1 mM EDTA, 10 mM Tris HC1 (pH 7.4; Medium B) and kept in boiling water for 5 minutes. Proteins were resolved in 5 to 13% gradient polyacrylamide gel in the presence of sodium dodecyl sulfate, transferred to nitrocellulose sheets, and autoradiographed on x-ray film.
As can be seen from Figure 1 , the addition of dibutyryl-cAMP resulted in a drastic increase of phosphorylation of Band 4.9. In contrast, with the addition of TPA the incorporation of 32 P was more pronounced in Band 4.1 than in Band 4.9. Inactive a-phorbol has no effect on membrane protein phosphorylation (data not presented). These results are in accordance with data reported by Home et al. 7 The synergistic effect of dibutyryl-cAMP and TPA (see Figure 1 , Lane IV) can be explained by the data on the difference in tryptic fragments phosphorylated in these proteins by kinase A and C. 7 We found the quantitative comparison of basal phosphorylation of Band 4.1 between essential hypertensive and normotensive subjects to be difficult because of the more extensive 32 P incorporation in Band 3 protein (see Figure 1 , Lane I). To investigate Band 4.9 phosphorylation in erythrocytes of patients with essential hypertension, strips of nitrocellulose membrane corresponding to this protein stained with Amidoschwarz 10B were cut and placed in Bray's solution. To minimize the possible differences between the activity of endogenous proteases, the stage of erythrocyte ghosts preparation was omitted and the reaction of zbestatin, and 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and centrifuged at 120,000 g for 45 minutes. Protein kinase C of the supernatant was partially purified by CM-Sephadex and diethylaminoethylcellulose chromatography. 
Erythrocyte Volume and Shape
The erythrocyte volume was measured with the Coulter counter (Model ZBIC-1000, Coultronics, Margency, France) at 20 °C. Influence of protein kinase activators on cell volume was determined after incubation of the erythrocytes at 37 °C in Medium C, consisting of 120 mM NaCl, 1.2 mM MgCl 2 , 1 mM CaCl 2 , 5 mM glucose, 20 mM HEPES NaOH (pH 7.4; H k = 0.5). The incubation was terminated by transfer of 100 /il of cell suspension into 900 /xl of cold Medium C; 10 ^.1 of this suspension was placed into 10 ml of isotonic solution (Isoton II, Coultronics).
Microscopic observation of erythrocyte shape was done with phase contrast optics. After incubation in Medium C with or without protein kinase activators, cells were fixed with 2.5% glutaraldehyde dissolved in the incubation medium. To calculate the number of cup-shaped cells, the samples were placed in the counting chamber.
"Rb Influx
To measure K Rb influx, 200 /AI of packed erythrocytes was transferred into 1 ml of Medium D, containing 130 mM NaCl, 3 mM KC1, 1 mM MgCl 2 , 1 mM CaCl 2 , 1 mM K 2 HPO 4 , 10 mM glucose, and 30 mM HEPES-Tris (pH 7.4; 37 °C), and preincubated for 30 minutes at 37 °C. The erythrocyte suspension was centrifuged (5000 rpm for 1-2 minutes; FP-9 centrifuge, Helsinki, Finland), and 0.8 ml of Medium D containing 4 jtCi/ml M Rb, used as a radioactive analogue of potassium, was added. In some cases, 0.2 mM ouabain and 0.25 mM furosemide were added. To determine the M Rb content in erythrocytes, 200 /il of cell suspension was placed into 1 ml of washing solution containing 150 mM choline chloride and 10 mM Tris HC1 (pH 7.4; 2-4 °C). The erythrocytes were sedimented, washed twice under the same conditions, and treated with 0.5 ml of 0.5% Triton X-100 and 0.5 ml of 10% trichloroacetic acid. After protein sedimentation, 0.8 ml of supernatant was transferred into Bray's solution. The kinetics of K Rb influx was linear up to 75 minutes of incubation. In accordance with these results the rate of the unidirectional ion flux was calculated as V = (A 2 -Ai)/amt, where A 2 and A, are the radioactivity of m liters of erythrocytes at 45 and 15 minutes of incubation (cpm), a is the specific radioactivity of the incubation medium (cpm//i.mol), and t is the incubation time (30 minutes).
The activity of the Na + -K + pump and Na + -K + cotransport were determined as the rates of ouabaininhibited and ouabain-insensitive furosemideinhibited components of ''Rb influx, respectively. In erythrocytes, 9 -10 as well as in other resting cells," the Na + -H + exchanger is quenched. To activate this ion transport system, we undertook the acidification of cytoplasm according to methods described by Escobales and Canessa. 12 First, 100 /xl of packed erythrocytes was placed into 1.9 ml of medium consisting of 150 mM NaCl, 1 mM KC1, 1 mM MgCl 2 , and 10 mM glucose. In some cases this medium contained 1 /nM of TPA. After 5 minutes of incubation (37 °C) the pH value was adjusted to 6.35-6.45 by a 0.2 N solution of HC1 in 150 mM NaCl. After addition of anion transport inhibitor (200 ^iM 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid; DIDS), the pH of incubation medium was increased to 7.95-8.05 by a 0.05 N solution of NaOH in 150 mM NaCl. In some experiments 0.5 mM amiloride was added before medium alkalization. The kinetics of proton efflux was indicated by a 91-15 electrode (Orion, Cambridge, MA, USA) connected to a PHM-64 (Radiometer, Copenhagen, Denmark). The rate of Na + -H + exchange was determined as (ApH, -ApHJ • b" 1 • m" 1 • t" 1 . Here, ApH, and ApH 2 are the initial rates of medium acidification without and with amiloride, respectively; b is the buffer capacity of the incubation medium (jxmo\ of H + per pH unit); m is the erythrocyte content in suspension (0.0001 L); / is the incubation time (1 minute). Na + -Li + countertransport was determined as described by Canessa et al. 13 TPA (1 /AM) was added both in Na + -containing and in Mg 2+ -containing mediums.
"Ca Influx
The rate of 43 Ca uptake by fresh erythrocytes is extremely low due to high Ca 2+ pump activity and insignificant intracellular Ca 2+ buffer capacity. 14 To enhance the last parameter, erythrocytes were loaded with quin 2 by methods described previously, 15 with slight modifications. Next, 200 p\ of packed erythrocytes was preincubated for 90 minutes at 37 °C in 800 ^1 of Medium D containing 1% VOL 12, No 3, SEPTEMBER 1988 bovine serum albumin and 100 fiM quin 2AM, washed with Medium D, and incubated for 30 minutes at 37 °C in the same medium. After sedimentation, erythrocytes were resuspended in four volumes of Medium D containing 43 CaCl 2 ,4 /nCi/ml, and incubated at 37 °C. At the fixed incubation times, the aliquots of suspension were transferred into 1 ml of the cold medium containing 150 mM NaCl, 5 mM sodium phosphate (pH 7.4), and 0.1 mM EDTA, sedimented, washed twice using the same medium, and treated with solutions of Triton X-100 and trichloroacetic acid as already described. The radioactivity of protein-free supernatant was determined in Bray's solution. 
Results

Phosphorylation of Band 4.9 Protein
As can be seen from Table 1 , the basal 32 P incorporation into Band 4.9 protein of erythrocytes of patients with essential hypertension was increased 1.6-fold to 1.8-fold as compared with that in normotensive subjects. TPA treatment increased this protein phosphorylation by 300 to 400%. Under these conditions we failed to see any differences between normotensive and hypertensive groups. ND Mean values ± SE are given. The number of patients is shown in parentheses. TPA = 12-0-tetradecanoylphorbol-13-acetate;EH = essential hypertensive; RH = renal hypertensive; ND = not determined. *p < 0.001, tp < 0.01, compared with respective value in normotensive subjects.
Erythrocyte Volume and Shape
We found a 4% decrease in the average volume of erythrocytes in essential hypertension (Table 2 ). While our manuscript was in preparation, we learned that similar results had already been obtained by Bruschi et al., 16 who also reported a decrease in erythrocyte volume in essential hypertension. As can be seen from Table 2 , the average volume of the erythrocytes of patients with renal hypertension did not differ from that of normotensive subjects. As can be seen in Table 2 and Figure 2 , a similar but more marked decrease of cell volume may be caused by the treatment of erythrocytes of healthy donors with TPA, but not with dibutyryl-cAMP.
As can be seen in Figure 3 , the addition of TPA induced monoconcave cup-shaped cell formation and, during a 10-minute incubation, the quota of PROTEIN KINASE C AND MEMBRANE ABNORMALITIES/fo^/iov et al.
these cells increased sevenfold to ninefold (see Table 2 ). Unexpectedly, an approximately threefold increase in the number of monoconcave cup-shaped erythrocytes was observed in patients with essential hypertension (see Table 2 ).
Protein Kinase C Activity
As can be seen in Table 3 , basal protein kinase activity in erythrocytes did not significantly differ between normotensive and essential hypertensive groups. The addition of phosphatidylserine and TPA resulted in an increase in protein kinase activity of 50 and 80%, respectively, in these groups. Protein kinase C activity in erythrocytes of patients with essential hypertension was increased by 60 to 70% as compared with that in the control group (see Table 3 ).
Ion Fluxes
The rate of Na + -Li + countertransport in erythrocytes of patients with essential hypertension was increased by 70 to 80% (Table 4 ). This observation is in accordance with data reported by Canessa et al. 13 and later confirmed in many laboratories (see reviews in References 17 and 18). We also found that the rate of Na + -K + cotransport (ouabaininsensitive furosemide-inhibited component of ^Rb influx) in erythrocytes of patients with essential hypertension was increased by 80%. Data on the increase of this component of ''Rb influx in erythrocytes of patients with essential hypertension have been reported by Bin Talib et al. 19 and Wambach et al. 20 To our knowledge, this is the first report of the twofold increase in the rate of proton electrochem- Means ± SE are given (in pmol n P/min/mg protein). Protein kinase was measured in the presence (+ PS) or absence (-PS) of phosphatidylserine and TPA as described under Subjects and Methods. APS refers to the phosphatidylserine and TPA-induced kinase activity (i.e., protein kinase C). See Table 2 for key to other abbreviations.
*p < 0.05, tp < 0.001, compared with respective value in normotensive subjects. ical gradient (A^i H +)-induced Na + -H + countertransport in erythrocytes of patients with essential hypertension (see Table 4 ). The rates of Na + -K + pump activity and 45 Ca influx in erythrocytes of normotensive and hypertensive patients did not differ.
As can be seen from Table 5 , the addition of TPA resulted in a fourfold increase in the rate of Na + -H + exchange (p < 0.0001). The same results have been obtained for Na + -H + exchange of Swiss 3T3 fibroblasts, sea urchin eggs, human epidermal carcinoma, human leukemic cells, human fibroblasts, HeLa cells, neuroblastoma, porcine neutrophils, and rat thymocytes and myoblasts (see review in Reference 11) . With the addition of TPA, the rates of Na + -K + pump activity, Na + -K + cotransport, and 45 Ca influx were increased by 20 to 50% (p = 0.12, p < 0.05, and p < 0.05, respectively). We failed to observe any effects of this protein kinase C activator on the rate of Na + -Li + countertransport. It should be stressed, however, that under lithium loading both the basal and TPA-induced levels of 32 P incorporation in erythrocyte membrane proteins are decreased twofold to fourfold (data not presented).
Discussion
The data obtained in this study show that the addition of protein kinase C activator (TPA) results in an increase of 32 P incorporation in Band 4.1 and 4.9 proteins as well as in an erythrocyte shape change and in a decrease of average cell volume. Similar but less marked alterations of these parameters were observed in erythrocytes of patients with essential hypertension (see Tables 1 and 2 ), in which activity of this enzyme was found to be increased (see Table 3 ). Does the protein kinase C act on erythrocyte shape and volume through the phosphorylation of Band 4.9, Band 4.1, or some minor membrane proteins (or all three)? To resolve this problem, additional experiments should be carried out.
In the mid-1970s, we showed that the passive (ouabain-insensitive) permeability of erythrocyte membrane for univalent cations is increased both in SHR 21 and in patients with essential hypertension. 22 Subsequent studies revealed that this abnormality is probably due to an increase of the rate of Na + -Na (Na + -Li + ) exchange 13 and Na + -K + cotransport. > 9 -20 The data displayed in Table 4 are in agreement with this assumption. The rates of both Na + -Li + countertransport and Na + -K + cotransport were increased about twofold in patients with essential hypertension. However, the maximal activation of protein kinase C by TPA did not modify Na + -Li + countertransport and enhanced the rate of Na + -K + cotransport by only 30% (see Table 5 ). Thus, the alteration of these ion transport systems found in hypertension is not the result of directed protein kinase C activation. On the other hand, Na + -H + exchange (registered as amiloride-inhibited proton efflux from erythrocytes with acidified cytoplasm; i.e., A/A H +-induced Na + -H + exchange), being enhanced twofold in hypertension, showed a clearer connection to protein kinase C activation. The influence of TPA on protein kinase C resulted in enhanced activity (fourfold) of this carrier.
Activation of the Na + -H + exchanger due to the influence of protein kinase C in cells other than erythrocytes has also been described (the data are summarized in Reference 11). An increased rate of A/i. H+ -induced Na + -H + exchange similar to the one described in this report has been shown for platelets of essential hypertensive patients 23 and thymocytes of SHR. 24 Together with our data, this shows the presence of widespread abnormalities in the Na + -H + exchanger, which can also be explained by increased protein kinase C activity.
The addition of TPA resulted in a 50% increase of the rate of 45 Ca influx in quin 2-loaded human erythrocytes (see Table 5 ). The rate of calcium influx in ATP-depleted erythrocytes of SHR also was found to be slightly increased. 25 However, we failed to observe any significant .alteration of this parameter in quin 2-loaded erythrocytes of patients with essential hypertension (see Table 4 ).
The activity of protein kinase C in cells is controlled by the level of diacylglycerol formed as a product of triphosphoinositide breakdown in a reaction catalyzed by phospholipase C. 26 Recently, it was shown that the increase of free intraerythrocyte calcium concentration is accompanied by an increase of membrane-bound protein kinase C. 27 Numerous data on alterations both in phosphoinositide metabolism and in intracellular calcium distribution in primary hypertension were recently summarized.
1 -17 -18 -M Further, the activity of protein kinase C may be enhanced, because of its limited proteolysis, by the calciumdependent proteinase calpain. 29 Evidence for enhanced activity of this enzyme in rat erythrocytes and the kidney cortex of the Milan hypertensive strain, 30 -31 as well as in erythrocytes of patients with essential hypertension, 32 -33 was recently demonstrated. In accordance with these data, several explanations of the enhanced protein kinase C activity in primary hypertension are offered: Further research is needed to determine which of these alternative explanations gives the most correct picture of the protein kinase C activation mechanism. Thus, activation of protein kinase C is able to bring about changes in the erythrocyte membrane skeleton, as well as in the function of some ion carriers, and these changes are, in principle, similar to those observed in primary hypertension. This finding provides evidence that the same mechanism is involved both in the case of essential hypertension and in in vitro TPA action. Apparently, this mechanism in primary hypertension is also present in other types of cells in which, as mentioned, membrane alterations have been observed, and the presence of increased protein kinase C activity in SHR platelets confirms this assumption. 34 
